These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38007382)

  • 1. Acromegaly and Cancer: An Update.
    Danilowicz K; Sosa S
    Arch Med Res; 2023 Dec; 54(8):102914. PubMed ID: 38007382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry.
    Maione L; Brue T; Beckers A; Delemer B; Petrossians P; Borson-Chazot F; Chabre O; François P; Bertherat J; Cortet-Rudelli C; Chanson P;
    Eur J Endocrinol; 2017 May; 176(5):645-655. PubMed ID: 28246150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors of cancers in acromegaly: a Chinese single-center retrospective study.
    Xiao T; Jiao R; Yang S; Wang Y; Bai X; Zhou J; Li R; Wang L; Yang H; Yao Y; Deng K; Gong F; Pan H; Duan L; Zhu H
    Endocrine; 2023 Nov; 82(2):368-378. PubMed ID: 37442901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid cancer is the most common cancer associated with acromegaly.
    Gullu BE; Celik O; Gazioglu N; Kadioglu P
    Pituitary; 2010 Sep; 13(3):242-8. PubMed ID: 20217483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update.
    Gadelha MR; Kasuki L; Lim DST; Fleseriu M
    Endocr Rev; 2019 Feb; 40(1):268-332. PubMed ID: 30184064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of diabetes in acromegaly associated neoplasia.
    Cheng S; Gomez K; Serri O; Chik C; Ezzat S
    PLoS One; 2015; 10(5):e0127276. PubMed ID: 25996963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic.
    Mercado M; Gonzalez B; Vargas G; Ramirez C; de los Monteros AL; Sosa E; Jervis P; Roldan P; Mendoza V; López-Félix B; Guinto G
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4438-46. PubMed ID: 25210882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry.
    Petroff D; Tönjes A; Grussendorf M; Droste M; Dimopoulou C; Stalla G; Jaursch-Hancke C; Mai M; Schopohl J; Schöfl C
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3894-902. PubMed ID: 26244491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study.
    Colao A; Grasso LFS; Di Cera M; Thompson-Leduc P; Cheng WY; Cheung HC; Duh MS; Neary MP; Pedroncelli AM; Maamari R; Pivonello R
    J Endocrinol Invest; 2020 Apr; 43(4):529-538. PubMed ID: 31741320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological complications of excess GH in acromegaly.
    Webb SM; Casanueva F; Wass JA
    Pituitary; 2002 Jan; 5(1):21-5. PubMed ID: 12638722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of malignant tumors in patients with acromegaly.
    Higuchi Y; Saeki N; Iuchi T; Uchino Y; Tatsuno I; Uchida D; Tanaka T; Noguchi Y; Nakamura S; Yasuda T; Yamaura A; Sunami K; Oka Y; Uozumi A
    Endocr J; 2000 Mar; 47 Suppl():S57-60. PubMed ID: 10890185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acromegaly: Update on Management and Long-Term Morbidities.
    Kasuki L; Antunes X; Lamback EB; Gadelha MR
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):475-486. PubMed ID: 32741483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased thyroid cancer risk in acromegaly.
    Dagdelen S; Cinar N; Erbas T
    Pituitary; 2014 Aug; 17(4):299-306. PubMed ID: 23836362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegaly, growth hormone and cancer risk.
    Renehan AG; Brennan BM
    Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):639-57. PubMed ID: 18971124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acromegaly: re-thinking the cancer risk.
    Loeper S; Ezzat S
    Rev Endocr Metab Disord; 2008 Mar; 9(1):41-58. PubMed ID: 18157698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does acromegaly enhance mortality?
    Ayuk J; Sheppard MC
    Rev Endocr Metab Disord; 2008 Mar; 9(1):33-9. PubMed ID: 18075787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels-A retrospective analysis from the UK Acromegaly Register 1970-2016.
    Orme S; McNally R; James PW; Davis J; Ayuk J; Higham C; Wass J;
    Clin Endocrinol (Oxf); 2024 Jun; 100(6):558-564. PubMed ID: 38652736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acromegaly and Colorectal Neoplasm: An Update.
    Kasuki L; Maia B; Gadelha MR
    Front Endocrinol (Lausanne); 2022; 13():924952. PubMed ID: 35795151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.